Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,435 | 203 | 99.3% |
| Education | $18.36 | 2 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $447.94 | 34 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $314.69 | 16 | $0 (2024) |
| Novo Nordisk Inc | $294.26 | 25 | $0 (2020) |
| Lilly USA, LLC | $286.84 | 22 | $0 (2024) |
| Daiichi Sankyo Inc. | $272.73 | 39 | $0 (2018) |
| Allergan, Inc. | $204.75 | 25 | $0 (2020) |
| AbbVie, Inc. | $178.89 | 19 | $0 (2017) |
| Kowa Pharmaceuticals America, Inc. | $142.72 | 11 | $0 (2022) |
| Amgen Inc. | $122.09 | 1 | $0 (2023) |
| PFIZER INC. | $117.45 | 8 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $170.67 | 4 | AstraZeneca Pharmaceuticals LP ($124.99) |
| 2023 | $148.32 | 3 | Amgen Inc. ($122.09) |
| 2022 | $196.19 | 14 | Lilly USA, LLC ($103.61) |
| 2021 | $319.84 | 27 | Janssen Pharmaceuticals, Inc ($117.90) |
| 2020 | $292.49 | 22 | AstraZeneca Pharmaceuticals LP ($87.19) |
| 2019 | $346.27 | 27 | Novo Nordisk Inc ($110.08) |
| 2018 | $238.28 | 20 | Novo Nordisk Inc ($118.68) |
| 2017 | $740.90 | 88 | Daiichi Sankyo Inc. ($259.82) |
All Payment Transactions
205 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/04/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $13.46 | General |
| Category: Diabetes | ||||||
| 08/29/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $17.75 | General |
| Category: Diabetes | ||||||
| 01/18/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Respiratory | ||||||
| 01/10/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $14.47 | General |
| Category: VACCINES | ||||||
| 10/31/2023 | Lilly USA, LLC | TRULICITY (Drug), MOUNJARO | Food and Beverage | In-kind items and services | $13.24 | General |
| Category: Diabetes | ||||||
| 03/15/2023 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | In-kind items and services | $122.09 | General |
| Category: Bone Health | ||||||
| 02/14/2023 | Lilly USA, LLC | TRULICITY (Drug), MOUNJARO | Food and Beverage | In-kind items and services | $12.99 | General |
| Category: Diabetes | ||||||
| 11/01/2022 | Lilly USA, LLC | TRULICITY (Drug), MOUNJARO | Food and Beverage | In-kind items and services | $13.42 | General |
| Category: Diabetes | ||||||
| 09/12/2022 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $14.05 | General |
| Category: Diabetes | ||||||
| 08/12/2022 | Lilly USA, LLC | TRULICITY (Drug), MOUNJARO | Food and Beverage | In-kind items and services | $13.57 | General |
| Category: Diabetes | ||||||
| 07/11/2022 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $12.04 | General |
| Category: Diabetes | ||||||
| 07/01/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.64 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/24/2022 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $13.40 | General |
| Category: Diabetes | ||||||
| 06/08/2022 | Lilly USA, LLC | — | Education | In-kind items and services | $11.71 | General |
| 04/22/2022 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $13.78 | General |
| Category: Diabetes | ||||||
| 04/21/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $18.49 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/24/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.75 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/11/2022 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug) | Food and Beverage | Cash or cash equivalent | $13.21 | General |
| Category: Cardiovascular | ||||||
| 02/11/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $18.49 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/07/2022 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug) | Food and Beverage | Cash or cash equivalent | $12.00 | General |
| Category: Cardiovascular | ||||||
| 01/14/2022 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $11.64 | General |
| Category: Diabetes | ||||||
| 12/17/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.64 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/23/2021 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $10.62 | General |
| Category: Diabetes | ||||||
| 11/17/2021 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug) | Food and Beverage | Cash or cash equivalent | $13.27 | General |
| Category: Cardiovascular | ||||||
| 10/29/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $12.17 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 911 | 1,224 | $190,912 | $54,938 |
| 2022 | 12 | 987 | 1,359 | $175,252 | $51,949 |
| 2021 | 11 | 918 | 1,307 | $161,594 | $71,504 |
| 2020 | 11 | 981 | 1,247 | $148,723 | $58,632 |
All Medicare Procedures & Services
45 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 168 | 304 | $78,816 | $16,860 | 21.4% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 44 | 44 | $21,087 | $12,413 | 58.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 143 | 143 | $38,979 | $7,873 | 20.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 79 | 113 | $19,559 | $5,253 | 26.9% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 56 | 57 | $8,000 | $3,888 | 48.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 204 | 342 | $5,898 | $2,873 | 48.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 58 | 59 | $2,774 | $1,979 | 71.3% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 43 | 43 | $2,242 | $1,429 | 63.7% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 12 | 12 | $4,912 | $1,056 | 21.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 91 | 93 | $5,225 | $818.39 | 15.7% |
| 69210 | Removal of impacted ear wax | Office | 2023 | 13 | 14 | $3,420 | $496.32 | 14.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 147 | 257 | $41,891 | $12,197 | 29.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 132 | 230 | $54,970 | $11,771 | 21.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 142 | 142 | $35,926 | $8,096 | 22.5% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 22 | 22 | $7,150 | $6,117 | 85.6% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 82 | 85 | $5,440 | $5,338 | 98.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 84 | 87 | $5,046 | $2,830 | 56.1% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 12 | 18 | $6,642 | $1,352 | 20.3% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 34 | 34 | $1,972 | $1,111 | 56.4% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 16 | 18 | $3,618 | $1,098 | 30.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 111 | 117 | $6,435 | $1,001 | 15.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 193 | 337 | $6,066 | $998.19 | 16.5% |
| 81002 | Urinalysis, manual test | Office | 2022 | 12 | 12 | $96.00 | $41.43 | 43.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 193 | 424 | $69,112 | $27,539 | 39.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 135 | 135 | $34,155 | $19,830 | 58.1% |
About Dr. Jeffrey Rednor, D.O
Dr. Jeffrey Rednor, D.O is a Family Medicine healthcare provider based in Trenton, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/26/2006. The National Provider Identifier (NPI) number assigned to this provider is 1184648149.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jeffrey Rednor, D.O has received a total of $2,453 in payments from pharmaceutical and medical device companies, with $170.67 received in 2024. These payments were reported across 205 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($2,435).
As a Medicare-enrolled provider, Rednor has provided services to 3,797 Medicare beneficiaries, totaling 5,137 services with total Medicare billing of $237,024. Data is available for 4 years (2020–2023), covering 45 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Trenton, NJ
- Active Since 07/26/2006
- Last Updated 07/08/2007
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1184648149
Products in Payments
- XARELTO (Drug) $405.43
- Saxenda (Drug) $251.98
- Movantik (Drug) $215.51
- TRULICITY (Drug) $197.78
- FARXIGA (Drug) $189.70
- Androgel (Drug) $178.89
- Livalo (Drug) $142.72
- AIRSUPRA (Drug) $124.99
- EVENITY (Biological) $122.09
- VRAYLAR (Drug) $74.53
- MOUNJARO (Drug) $70.70
- CHANTIX (Drug) $64.18
- Welchol (Drug) $57.22
- VIAGRA (Drug) $53.27
- INVOKANA (Drug) $42.51
- Ozempic (Drug) $42.28
- VIBERZI (Drug) $36.85
- LINZESS (Drug) $35.78
- SHINGRIX (Biological) $29.96
- JANUVIA (Drug) $26.82
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Trenton
Dr. Michael Ducato, Md, MD
Family Medicine — Payments: $27,288
Jennifer Fretz, D.o, D.O
Family Medicine — Payments: $16,214
Dr. James Williams, Md, MD
Family Medicine — Payments: $14,581
Dr. Cresandra Corbin, M.d, M.D
Family Medicine — Payments: $7,729
Dr. Michelle Bauer, Do, DO
Family Medicine — Payments: $4,098
Paul Walker, D.o, D.O
Family Medicine — Payments: $2,917